Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy

DSpace Repository

Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy

Author: Amaral, Teresa; Chatziioannou, Eftychia; Nuebling, Alica; Nanz, Lena; Sinnberg, Tobias; Niessner, Heike; Arentsen, Tim; Ruiter, Romy; Dwarkasing, Jvalini; Eggermont, Alexander M.; Leiter, Ulrike; Flatz, Lukas; Forchhammer, Stephan
Tübinger Autor(en):
Amaral, Teresa
Chatziioannou, Eftychia
Nuebling, Alica
Nanz, Lena
Sinnberg, Tobias
Niessner, Heike
Flatz, Lukas
Forchhammer, Stephan
Leiter-Stöppke, Ulrike
Published in: European Journal of Cancer (2025), Bd. 220, Article 115372
Verlagsangabe: London : Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2025.115372
ISSN: 0959-8049
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)